Delivery Order SPE2DB22D1052-SPE2DB25FV0AH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.42 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a joint care injection medication. This firm fixed-price contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,985.24 to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6ml). This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Synvisc-One is a...
- The Defense Logistics Agency awarded a $13,303.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6mL) on September 15, 2025, with an ultimate completion date of September 16, 2025. The award, which carries no set-aside designation, represents a competitive procurement fulfilled by the pharmaceutical distributor from its Conshohocken, Pennsylvania corporate office. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,398.41 on July 29, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $3,885.12 under a firm fixed-price contract type. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,729.05 delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a pharmaceutical product used in joint pain management. This firm fixed price contract, issued on July 29, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order specifies a place of performance in...
- The Defense Logistics Agency Medical Supply Chain awarded a $58,094.55 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Synvisc-One syringes (6ML, 1 unit). The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. This...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,717.23, for the delivery of Synvisc-One syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This is a firm fixed price delivery order with a ceiling value of $6,009.24 and an ultimate completion date of July 2, 2025. The contract represents a non-competitive award utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Synvisc-One Syringe 6ML, a pharmaceutical product used in joint pain management. This is a firm fixed price delivery order with a ceiling value of $17,220.22 and an ultimate completion date of September 17, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating it was...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FV0AHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,939.45 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and specialized medical devices across multiple therapeutic domains. The contractor has demonstrated its capability to meet federal procurement requirements consistently through competitive awards across diverse medical supply categories serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/5/25 |